Abstract
GTD is a rare abnormal condition of pregnancy, where the condition occurs when trophoblast cells proliferate uncontrollably so that it develops into an abnormal pregnancy. Abnormal pregnancy can lead to various negative effects such as vaginal bleeding, shortness of breath, and others. The high incidence of GTD is still not well documented to date. It is important to manage GTD appropriately to minimize acute complications and identify gestational trophoblastic tumor promptly. In this study, studyers took data from the oncogynecology register book regarding GTD and then presented it as descriptive data so that descriptive data analysis was carried out in the form of tables and narratives. The results of this study showed that GTD was highest in the age range of 31-35 years, parity 2, clinical symptoms of vaginal bleeding, previous pregnancy history with hydatidiform mole, gestational interval of 4 months or less, β-HCG level more than 100.000 mIU/ml, no metastases, histopathology of complete hydatidiform mole, stage I GTD, and receiving metrotrexate chemotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
